Interest in the gut microbiome as a therapeutic target for treating alopecia areata (AA) has grown considerably. However, existing evidence remains limited and inconsistent. Currently, there is insufficient evidence to recommend microbiome-directed testing and therapies to patients with AA. Rigorous longitudinal studies are needed before such interventions can be recommended.
McMullen et al. (Fri,) studied this question.